Meryl Waldman

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Treatment of idiopathic membranous nephropathy
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    J Am Soc Nephrol 23:1617-30. 2012
  2. ncbi request reprint Update on the treatment of lupus nephritis
    M Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, Maryland 20892, USA
    Kidney Int 70:1403-12. 2006
  3. ncbi request reprint Adult minimal-change disease: clinical characteristics, treatment, and outcomes
    Meryl Waldman
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Clin J Am Soc Nephrol 2:445-53. 2007
  4. pmc Viruses and kidney disease: beyond HIV
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 1268, USA
    Semin Nephrol 28:595-607. 2008
  5. pmc Controversies in the treatment of idiopathic membranous nephropathy
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Nat Rev Nephrol 5:469-79. 2009
  6. ncbi request reprint Parvovirus-B19-associated complications in renal transplant recipients
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20814 9692, USA
    Nat Clin Pract Nephrol 3:540-50. 2007
  7. ncbi request reprint Parvovirus B19 and the kidney
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1268, USA
    Clin J Am Soc Nephrol 2:S47-56. 2007

Detail Information

Publications7

  1. pmc Treatment of idiopathic membranous nephropathy
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    J Am Soc Nephrol 23:1617-30. 2012
    ....
  2. ncbi request reprint Update on the treatment of lupus nephritis
    M Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, Maryland 20892, USA
    Kidney Int 70:1403-12. 2006
    ..We also review the experimental and human data regarding some of the novel targeted forms of therapy that are under investigation and in different phases of clinical trials...
  3. ncbi request reprint Adult minimal-change disease: clinical characteristics, treatment, and outcomes
    Meryl Waldman
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Clin J Am Soc Nephrol 2:445-53. 2007
    ..Second-line agents give greater response in patients who are steroid dependent. ARF occurs in a significant number of adult MCD patients and may leave residual renal dysfunction. Few patients progress to ESRD...
  4. pmc Viruses and kidney disease: beyond HIV
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 1268, USA
    Semin Nephrol 28:595-607. 2008
    ..We also discuss an approach to the identification of new viral renal pathogens, using a viral gene chip to identify viral DNA or RNA...
  5. pmc Controversies in the treatment of idiopathic membranous nephropathy
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Nat Rev Nephrol 5:469-79. 2009
    ..This paper reviews the available evidence regarding both established and new agents for the treatment of patients with idiopathic membranous nephropathy, with an emphasis on the results of the most recent clinical trials...
  6. ncbi request reprint Parvovirus-B19-associated complications in renal transplant recipients
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20814 9692, USA
    Nat Clin Pract Nephrol 3:540-50. 2007
    ..Most patients benefit from intravenous immunoglobulin therapy and/or alteration or reduction of immunosuppressive therapy. Conservative therapy might be sufficient in some cases...
  7. ncbi request reprint Parvovirus B19 and the kidney
    Meryl Waldman
    Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1268, USA
    Clin J Am Soc Nephrol 2:S47-56. 2007
    ..Allograft rejection and dysfunction have been reported in association with infection, but a cause-effect relationship has not been proved. Further investigation of the relationship between B19 and kidney disease is warranted...